6 days Ago By ABMN Staff
Astera Labs ( NASDAQ:ALAB – Free Report ) had its price objective reduced by Citigroup from $120.00 to $100.00 in a research report sent to investors on Monday, Benzinga reports.
Citigroup currently has a buy rating on the stock. Other research analysts also recently issued reports about the company. Craig Hallum lifted their target price on Astera Labs from $105.
00 to $125.00 and gave the stock a “buy” rating in a research note on Tuesday, February 11th. Needham & Company LLC reaffirmed a “buy” rating and set a $140.
00 target price on shares of Astera Labs in a report on Tuesday, February 11th. Northland Securities raised shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $120.00 price target on the stock in a report on Tuesday, January 28th.
Barclays upped their price objective on Astera Labs from $87.00 to $135.00 and gave the company an “overweight” rating in a report on Friday, January 17th.
Finally, Morgan Stanley decreased their target price on shares of Astera Labs from $142.00 to $114.00 and set an “equal weight” rating on the stock in a research report on Tuesday, January 28th.
One equities research analyst has rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $111.23.
Read Our Latest Analysis on ALAB Astera Labs Trading Down 1.2 % Astera Labs ( NASDAQ:ALAB – Get Free Report ) last posted its quarterly earnings results on Monday, February 10th. The company reported $0.
10 earnings per share for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.16).
Astera Labs had a negative net margin of 21.05% and a negative return on equity of 10.40%.
As a group, equities research analysts forecast that Astera Labs will post 0.34 EPS for the current fiscal year. Insider Activity at Astera Labs In related news, General Counsel Philip Mazzara sold 50,000 shares of the stock in a transaction on Thursday, February 20th.
The stock was sold at an average price of $87.46, for a total value of $4,373,000.00.
Following the completion of the sale, the general counsel now directly owns 191,209 shares of the company’s stock, valued at approximately $16,723,139.14. This represents a 20.
73 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website . Also, Director Michael E.
Hurlston sold 2,500 shares of the company’s stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $92.08, for a total transaction of $230,200.
00. Following the completion of the sale, the director now owns 91,794 shares of the company’s stock, valued at approximately $8,452,391.52.
The trade was a 2.65 % decrease in their position. The disclosure for this sale can be found here .
Insiders have sold 633,990 shares of company stock worth $54,235,012 in the last quarter. Hedge Funds Weigh In On Astera Labs Several institutional investors have recently added to or reduced their stakes in the stock. Whittier Trust Co.
of Nevada Inc. bought a new position in Astera Labs during the fourth quarter worth about $25,000. Steward Partners Investment Advisory LLC raised its stake in shares of Astera Labs by 99.
0% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 199 shares of the company’s stock valued at $26,000 after purchasing an additional 99 shares during the period. Kestra Investment Management LLC purchased a new stake in Astera Labs during the 4th quarter worth about $28,000.
Geneos Wealth Management Inc. purchased a new stake in shares of Astera Labs in the fourth quarter worth about $36,000. Finally, Global Retirement Partners LLC lifted its holdings in shares of Astera Labs by 3,155.
6% in the fourth quarter. Global Retirement Partners LLC now owns 293 shares of the company’s stock worth $39,000 after buying an additional 284 shares in the last quarter. Institutional investors own 60.
47% of the company’s stock. About Astera Labs ( Get Free Report ) Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Recommended Stories Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter ..
